Literature DB >> 22571913

Range uncertainties in proton therapy and the role of Monte Carlo simulations.

Harald Paganetti1.   

Abstract

The main advantages of proton therapy are the reduced total energy deposited in the patient as compared to photon techniques and the finite range of the proton beam. The latter adds an additional degree of freedom to treatment planning. The range in tissue is associated with considerable uncertainties caused by imaging, patient setup, beam delivery and dose calculation. Reducing the uncertainties would allow a reduction of the treatment volume and thus allow a better utilization of the advantages of protons. This paper summarizes the role of Monte Carlo simulations when aiming at a reduction of range uncertainties in proton therapy. Differences in dose calculation when comparing Monte Carlo with analytical algorithms are analyzed as well as range uncertainties due to material constants and CT conversion. Range uncertainties due to biological effects and the role of Monte Carlo for in vivo range verification are discussed. Furthermore, the current range uncertainty recipes used at several proton therapy facilities are revisited. We conclude that a significant impact of Monte Carlo dose calculation can be expected in complex geometries where local range uncertainties due to multiple Coulomb scattering will reduce the accuracy of analytical algorithms. In these cases Monte Carlo techniques might reduce the range uncertainty by several mm.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22571913      PMCID: PMC3374500          DOI: 10.1088/0031-9155/57/11/R99

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  64 in total

1.  In vivo proton beam range verification using spine MRI changes.

Authors:  Michael F Gensheimer; Torunn I Yock; Norbert J Liebsch; Gregory C Sharp; Harald Paganetti; Neel Madan; P Ellen Grant; Thomas Bortfeld
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-05-17       Impact factor: 7.038

2.  Accuracy of proton beam range verification using post-treatment positron emission tomography/computed tomography as function of treatment site.

Authors:  Antje-Christin Knopf; Katia Parodi; Harald Paganetti; Thomas Bortfeld; Juliane Daartz; Martijn Engelsman; Norbert Liebsch; Helen Shih
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-06-18       Impact factor: 7.038

3.  Dosimetric accuracy of planning and delivering small proton therapy fields.

Authors:  Bryan Bednarz; Juliane Daartz; Harald Paganetti
Journal:  Phys Med Biol       Date:  2010-11-19       Impact factor: 3.609

4.  The impact of uncertainties in the CT conversion algorithm when predicting proton beam ranges in patients from dose and PET-activity distributions.

Authors:  Samuel España; Harald Paganetti
Journal:  Phys Med Biol       Date:  2010-11-19       Impact factor: 3.609

5.  Radiological use of fast protons.

Authors:  R R WILSON
Journal:  Radiology       Date:  1946-11       Impact factor: 11.105

6.  Measurement and calculation of characteristic prompt gamma ray spectra emitted during proton irradiation.

Authors:  J C Polf; S Peterson; M McCleskey; B T Roeder; A Spiridon; S Beddar; L Trache
Journal:  Phys Med Biol       Date:  2009-10-28       Impact factor: 3.609

Review 7.  Proton radiation in the management of localized cancer.

Authors:  Harald Paganetti; Hanne Kooy
Journal:  Expert Rev Med Devices       Date:  2010-03       Impact factor: 3.166

8.  Theoretical variance analysis of single- and dual-energy computed tomography methods for calculating proton stopping power ratios of biological tissues.

Authors:  M Yang; G Virshup; J Clayton; X R Zhu; R Mohan; L Dong
Journal:  Phys Med Biol       Date:  2010-02-10       Impact factor: 3.609

9.  Monte Carlo patient study on the comparison of prompt gamma and PET imaging for range verification in proton therapy.

Authors:  M Moteabbed; S España; H Paganetti
Journal:  Phys Med Biol       Date:  2011-01-25       Impact factor: 3.609

10.  The reliability of proton-nuclear interaction cross-section data to predict proton-induced PET images in proton therapy.

Authors:  S España; X Zhu; J Daartz; G El Fakhri; T Bortfeld; H Paganetti
Journal:  Phys Med Biol       Date:  2011-04-05       Impact factor: 3.609

View more
  215 in total

1.  Proton dose calculation on scatter-corrected CBCT image: Feasibility study for adaptive proton therapy.

Authors:  Yang-Kyun Park; Gregory C Sharp; Justin Phillips; Brian A Winey
Journal:  Med Phys       Date:  2015-08       Impact factor: 4.071

Review 2.  Robust Proton Treatment Planning: Physical and Biological Optimization.

Authors:  Jan Unkelbach; Harald Paganetti
Journal:  Semin Radiat Oncol       Date:  2018-04       Impact factor: 5.934

3.  Initial development of goCMC: a GPU-oriented fast cross-platform Monte Carlo engine for carbon ion therapy.

Authors:  Nan Qin; Marco Pinto; Zhen Tian; Georgios Dedes; Arnold Pompos; Steve B Jiang; Katia Parodi; Xun Jia
Journal:  Phys Med Biol       Date:  2017-01-31       Impact factor: 3.609

4.  Material elemental decomposition in dual and multi-energy CT via a sparsity-dictionary approach for proton stopping power ratio calculation.

Authors:  Chenyang Shen; Bin Li; Liyuan Chen; Ming Yang; Yifei Lou; Xun Jia
Journal:  Med Phys       Date:  2018-02-23       Impact factor: 4.071

5.  Density overwrites of internal tumor volumes in intensity modulated proton therapy plans for mobile lung tumors.

Authors:  Pablo Botas; Clemens Grassberger; Gregory Sharp; Harald Paganetti
Journal:  Phys Med Biol       Date:  2018-01-30       Impact factor: 3.609

6.  Experimental validation of the TOPAS Monte Carlo system for passive scattering proton therapy.

Authors:  M Testa; J Schümann; H-M Lu; J Shin; B Faddegon; J Perl; H Paganetti
Journal:  Med Phys       Date:  2013-12       Impact factor: 4.071

7.  Helium CT: Monte Carlo simulation results for an ideal source and detector with comparison to proton CT.

Authors:  Pierluigi Piersimoni; Bruce A Faddegon; José Ramos Méndez; Reinhard W Schulte; Lennart Volz; Joao Seco
Journal:  Med Phys       Date:  2018-05-20       Impact factor: 4.071

8.  Feasibility of proton-activated implantable markers for proton range verification using PET.

Authors:  Jongmin Cho; Geoffrey Ibbott; Michael Gillin; Carlos Gonzalez-Lepera; Uwe Titt; Harald Paganetti; Matthew Kerr; Osama Mawlawi
Journal:  Phys Med Biol       Date:  2013-10-08       Impact factor: 3.609

9.  High-dose-rate brachytherapy of rhabdomyosarcoma limited to the external auditory canal.

Authors:  Martin T King; Laszlo Voros; Gil'ad N Cohen; Ryan M Lanning; Ian Ganly; Chibuzo C O'Suoji; Suzanne L Wolden
Journal:  Brachytherapy       Date:  2016-08-12       Impact factor: 2.362

10.  Feasibility of Using Distal Endpoints for In-room PET Range Verification of Proton Therapy.

Authors:  Kira Grogg; Xuping Zhu; Chul Hee Min; Brian Winey; Thomas Bortfeld; Harald Paganetti; Helen A Shih; Georges El Fakhri
Journal:  IEEE Trans Nucl Sci       Date:  2013-10       Impact factor: 1.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.